JPMorgan Chase & Co’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-499,936
| Closed | -$48.5M | – | 4990 |
|
|
2019
Q3 | $48.5M | Sell |
499,936
-183,079
| -27% | -$17.8M | 0.01% | 879 |
|
|
2019
Q2 | $69.8M | Sell |
683,015
-347,827
| -34% | -$35.5M | 0.01% | 739 |
|
|
2019
Q1 | $117M | Sell |
1,030,842
-1,452,603
| -58% | -$165M | 0.02% | 555 |
|
|
2018
Q4 | $97.2M | Buy |
2,483,445
+155,541
| +7% | +$6.09M | 0.02% | 576 |
|
|
2018
Q3 | $127M | Buy |
2,327,904
+25,337
| +1% | +$1.38M | 0.02% | 550 |
|
|
2018
Q2 | $191M | Sell |
2,302,567
-112,640
| -5% | -$9.32M | 0.04% | 421 |
|
|
2018
Q1 | $161M | Buy |
2,415,207
+175,622
| +8% | +$11.7M | 0.03% | 453 |
|
|
2017
Q4 | $115M | Buy |
2,239,585
+390,597
| +21% | +$20.1M | 0.02% | 542 |
|
|
2017
Q3 | $165M | Buy |
1,848,988
+241,016
| +15% | +$21.5M | 0.04% | 441 |
|
|
2017
Q2 | $96.1M | Buy |
1,607,972
+58,879
| +4% | +$3.52M | 0.02% | 593 |
|
|
2017
Q1 | $82.6M | Buy |
1,549,093
+112,596
| +8% | +$6.01M | 0.02% | 637 |
|
|
2016
Q4 | $71.7M | Buy |
1,436,497
+100,006
| +7% | +$4.99M | 0.02% | 650 |
|
|
2016
Q3 | $80.3M | Sell |
1,336,491
-13,089
| -1% | -$786K | 0.02% | 580 |
|
|
2016
Q2 | $69M | Buy |
1,349,580
+670,360
| +99% | +$34.3M | 0.02% | 631 |
|
|
2016
Q1 | $20M | Buy |
679,220
+86,659
| +15% | +$2.56M | 0.01% | 1208 |
|
|
2015
Q4 | $26.8M | Buy |
592,561
+541,845
| +1,068% | +$24.6M | 0.01% | 1019 |
|
|
2015
Q3 | $2.12M | Sell |
50,716
-39,170
| -44% | -$1.64M | ﹤0.01% | 2339 |
|
|
2015
Q2 | $5.42M | Buy |
89,886
+46,888
| +109% | +$2.83M | ﹤0.01% | 2042 |
|
|
2015
Q1 | $3.33M | Buy |
+42,998
| New | +$3.33M | ﹤0.01% | 2309 |
|